2 reports

The division continues to be on track for a spring U. S. launch of the MiniMed®##G system, the world' s first hybrid closed loop insulin delivery system.

  • Clinical Trial
  • Genitourinary System Disease
  • Surgery
  • United States
  • GlobalData's company

Direct Activation of the Angiotensin II Type-## Receptors Enhances Muscle Microvascular Perfusion, Oxygenation and Insulin Delivery in Male Rats".

  • Diabetes
  • Genitourinary System Disease
  • United States
  • Company
  • Product Initiative